Technology News and Research

RSS

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

The American Association for Thoracic Surgery, a professional organization of surgeons dedicated to the diagnosis, treatment, and cure of diseases of the chest, strongly supports the United States Preventive Services Task Force draft recommendation for lung cancer screening of asymptomatic smokers.

29 Aug 2013

Deadline reportedly delayed for finalizing details with insurance plans on federal exchanges

Reuters reports these agreements are not likely to be signed until mid-September. Also in the news, the race is on to train navigators while, in Washington state, Group Health makes a decision about abortion coverage in exchange plans. And Republicans on Capitol Hill offer a new plan for insuring government officials.

29 Aug 2013

WPI researchers receive NIH grant to develop cell therapies for healing cardiac muscle

The National Institutes of Health (NIH) has awarded a five-year, $1.94 million grant to a biomedical research team at Worcester Polytechnic Institute (WPI) working at the forefront of cell therapies for healing cardiac muscle damaged by heart attack or chronic disease.

29 Aug 2013

Endo Eyes Generics Growth With $225M Boca Pharmacal Acquisition

...

28 Aug 2013

Tumor Suppressor May Actually Drive Cancer Development

...

28 Aug 2013

JCVI Receives $1.25M For Healthy Aging Study

...

28 Aug 2013

University Of Virginia Gets $14.4M Grant To Fight Hypertrophic Cardiomyopathy

...

28 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

Now secure digital links with Cambridge Consultants' Trusted Source system

Companies can now secure their digital links with Trusted Source – a new, cost-effective, easy-to-implement turnkey platform devised by product development firm Cambridge Consultants.

28 Aug 2013

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration has categorized Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments.

28 Aug 2013

SDSU researchers develop new device to accurately diagnose concussions from sidelines

In the United States there are millions of sports related concussions each year, but many go undiagnosed because for some athletes, the fear of being benched trumps the fear of permanent brain damage, and there is no objective test available to accurately diagnose concussions on the sidelines.

28 Aug 2013

Respicardia reports successful implant of remede System for CSA patients

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.

28 Aug 2013

RL Solutions announces availability of new incident and patient feedback reporting app

RL Solutions, creators of innovative and easy-to-use healthcare quality and safety software, announced today the general availability of its new incident and patient feedback reporting app, RL6:Mobile.

28 Aug 2013

Kessler Foundation scientist evaluates virtual reality office task in participants with MS and TBI

Denise Krch, Ph.D., research scientist for Traumatic Brain Injury Research at Kessler Foundation, presented "Pilot results from a virtual reality executive function task," at the International Conference on Virtual Rehabilitation. In the pilot study, Dr. Krch evaluated the Assessim Office, a virtual reality office task, in participants with multiple sclerosis and TBI.

28 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

UW researchers perform first noninvasive human-to-human brain interface

University of Washington researchers have performed what they believe is the first noninvasive human-to-human brain interface, with one researcher able to send a brain signal via the Internet to control the hand motions of a fellow researcher.

28 Aug 2013

Funds to support study of telephone-based treatment program for lung cancer patients

An assistant professor of psychology in the School of Science at IUPUI will apply nearly $1 million in recently approved grants to study how a telephone-based treatment process can help ease stress and anxiety issues experienced by advanced-stage lung cancer patients and the family members who care for them.

28 Aug 2013

Study shows genetic test to classify gastric cancers and match them to therapies offer best outcomes

Stomach cancer, one of the leading causes of cancer death worldwide, actually falls into three broad subtypes that respond differently to currently available therapies, according to researchers at Duke-NUS Graduate Medical School Singapore.

28 Aug 2013

Ohio State doctor shows promise of Google Glass in live surgery

A surgeon at The Ohio State University Wexner Medical Center is the first in the United States to consult with a distant colleague using live, point-of-view video from the operating room via Google Glass, a head-mounted computer and camera device.

28 Aug 2013

Report shows women affected by DCIS prefer nonsurgical treatments

When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.

28 Aug 2013

Technology News and Research

AATS agrees with USPSTF recommendation for lung cancer screening of asymptomatic smokers

Deadline reportedly delayed for finalizing details with insurance plans on federal exchanges

WPI researchers receive NIH grant to develop cell therapies for healing cardiac muscle

Endo Eyes Generics Growth With $225M Boca Pharmacal Acquisition

Tumor Suppressor May Actually Drive Cancer Development

JCVI Receives $1.25M For Healthy Aging Study

University Of Virginia Gets $14.4M Grant To Fight Hypertrophic Cardiomyopathy

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Now secure digital links with Cambridge Consultants' Trusted Source system

FDA categorizes Cepheid's Xpert MTB/RIF test as 'Moderate Complexity' under CLIA

SDSU researchers develop new device to accurately diagnose concussions from sidelines

Respicardia reports successful implant of remede System for CSA patients

RL Solutions announces availability of new incident and patient feedback reporting app

Kessler Foundation scientist evaluates virtual reality office task in participants with MS and TBI

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

UW researchers perform first noninvasive human-to-human brain interface

Funds to support study of telephone-based treatment program for lung cancer patients

Study shows genetic test to classify gastric cancers and match them to therapies offer best outcomes

Ohio State doctor shows promise of Google Glass in live surgery

Report shows women affected by DCIS prefer nonsurgical treatments

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News